The Relevance of Using 5α-Reductase Inhibitors in the Conservative Management of Benign Prostatic Hyperplasia: A Review

    September 2025 in “ Consilium Medicum
    Adel S. Al-Shukri
    Image of study
    TLDR 5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.
    The review discusses the increasing incidence of benign prostatic hyperplasia (BPH) and its impact on younger populations, highlighting the need for effective treatment strategies. It emphasizes the role of 5α-reductase inhibitors in managing lower urinary tract symptoms (LUTS) associated with BPH. These inhibitors are shown to slow disease progression and prepare patients for surgery, reducing peri- and postoperative risks. Additionally, the article considers the potential of 5α-reductase inhibitors in prostate cancer chemoprevention and treating androgenetic alopecia, indicating their broader therapeutic applications.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 139 results

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Fresh off the press: Dutasteride may cause chronic infertility

      in Research/Science  643 upvotes 5 months ago
      Dutasteride may cause chronic infertility by reducing semen volume and motility, with concerns about irreversible prostate fibrosis. Users consider switching to finasteride or using treatments like minoxidil and microneedling, weighing hair preservation against fertility.

    Similar Research

    6 / 1000+ results